Skip to content Skip to sidebar Skip to footer
starpharma
Starpharma (ASX: SPL) Soars 70% on Genentech Deal
Starpharma Lands Genentech Collaboration Starpharma (ASX: SPL) has caught investor attention with a stunning 70 percent share price surge after unveiling a collaboration with global biotech giant Genentech. At the heart of the deal is Starpharma’s DEP platform, which uses dendrimers—tiny, tree-like molecules designed to carry cancer drugs more effectively through the body. By “loading”…
vection
Vection Technologies (ASX: VR1) Surges 30% – What Sparked the Rally and What Comes Next?
Vection Technologies Soars on A$22 Million NATO Defence Deal — A Turning Point or Just a Spark? Vection Technologies (ASX: VR1) has kicked off the week with a surge of more than 30 percent, fueled by news of a multi-year agreement with a NATO-approved partner in the European defence sector. The deal, worth around A$22…

Stocks Down Under (Pitt Street Research AFSL 1265112) provides actionable investment ideas on ASX-listed stocks. This content provides general information only and does not constitute financial advice. Always do your own research before making investment decisions. © 2026 Stock Down Under. All Rights Reserved.

© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here